Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 3081 - 3090 of 141793 results

First page
Previous page
Next page
Next page

Cipepofol

M3WGS532VY

Search for Structure

Status:

Investigational

Source:

NCT04711837: Phase 3 Interventional Completed Anesthesia

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04711837

Class (Stereo):

CHEMICAL (ABSOLUTE)

LY-900009

PX8XQ3H3RV

Search for Structure

Status:

Investigational

Source:

NCT01158404: Phase 1 Interventional Completed Advanced Cancer

(2010)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01158404

Class (Stereo):

CHEMICAL (ABSOLUTE)

OBAFISTAT

29714ZC6VZ

Search for Structure

Status:

Investigational

Source:

INN:obafistat [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/29714ZC6VZ

Class (Stereo):

CHEMICAL (ACHIRAL)

JNJ-17166864 CATION

2BOD5IUD08

Search for Structure

Status:

Investigational

Source:

NCT00604123: Phase 2 Interventional Completed Allergic Rhinitis

(2008)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00604123

Class (Stereo):

CHEMICAL (ACHIRAL)

INUPADENANT

HQ700V0X06

Search for Structure

Status:

Investigational

Source:

NCT03873883: Phase 1 Interventional Completed Solid Tumor, Adult

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03873883

Class (Stereo):

CHEMICAL (ABSOLUTE)

Soquelitinib

6I5H17AN3I

Search for Structure

Status:

Investigational

Source:

INN:soquelitinib [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/6I5H17AN3I

Class (Stereo):

CHEMICAL (ABSOLUTE)

Nerandomilast

I5DGT51IB8

Search for Structure

Status:

Investigational

Source:

INN:nerandomilast [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/I5DGT51IB8

Class (Stereo):

CHEMICAL (ABSOLUTE)

Golidocitinib

3BY9Z3M34G

Search for Structure

Status:

Investigational

Source:

NCT04105010: Phase 2 Interventional Completed Relapsed or Refractory Peripheral T Cell Lymphoma

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04105010

Class (Stereo):

CHEMICAL (ABSOLUTE)

LANIFIBRANOR

28Q8AG0PYL

Search for Structure

Status:

Investigational

Source:

NCT03459079: Phase 2 Interventional Completed Nonalcoholic Fatty Liver Disease (NAFLD)

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03459079

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Peroxisome proliferator-activated receptor gamma

Peroxisome proliferator-activated receptor delta

Peroxisome proliferator-activated receptor alpha

IVA-337 (LANIFIBRANOR), an indole sulfonamide derivative, is a pan peroxisome proliferator-activated receptor (PPAR) agonist. It is under investigation in Phase 2 clinical trials for non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, and type 2 diabetes.

MMI-0100

6VP6PBL1ZH

Search for Structure

Status:

Investigational

Source:

NCT02515396: Phase 1 Interventional Unknown status Acute Inflammatory Response to Non-antigenic Stimulus

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02515396

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of Cipepofol

ABSOLUTE

Structure of LY-900009

ABSOLUTE

Structure of OBAFISTAT

ACHIRAL

Structure of JNJ-17166864 CATION

ACHIRAL

JNJ-17166864 CATION

Structure of INUPADENANT

ABSOLUTE

Structure of Soquelitinib

ABSOLUTE

Structure of Nerandomilast

ABSOLUTE

Structure of Golidocitinib

ABSOLUTE

Structure of LANIFIBRANOR

ACHIRAL

6VP6PBL1ZH
Not a public record

Structure of MMI-0100

ABSOLUTE

Showing 3081 - 3090 of 141793 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1